Cow Vetch (Vicia cracca)

Cow vetch (Vicia cracca) is a leguminous plant containing flavonoids, tannins, and cyanogenic glycosides that are thought to contribute to its antioxidant and anti-inflammatory activities. Research remains largely preclinical and genus-level, with no confirmed human clinical trials specifically validating its therapeutic use.

Origin & History

Cow Vetch (Vicia cracca) is a perennial legume native to Europe, temperate Asia, and parts of North America. It thrives in well-drained, moist soils and is typically harvested in whole or parts for traditional uses.

Historical & Cultural Context

Cow Vetch has been used in European and Native American traditional medicine primarily for food and wound care. It was introduced in North America around 1860 and used by various Native American tribes for diverse ailments.

Health Benefits

• Antioxidant properties noted in Vicia genus studies, though specific to Vicia cracca are not confirmed due to lack of human trials.
• Anti-inflammatory effects suggested in genus-level reviews, but human-specific data for V. cracca is absent.
• Potential antidiabetic activities inferred from the Vicia genus but unsupported by direct human studies for V. cracca.
• Traditional use as a galactogogue suggests benefits in lactation, though not clinically validated.
• Used for wound care as an antiseptic poultice in traditional medicine, lacking modern clinical confirmation.

How It Works

Flavonoids isolated from Vicia species, including kaempferol and quercetin derivatives, are believed to inhibit pro-inflammatory enzymes such as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX), reducing prostaglandin synthesis. Tannins and polyphenols in V. cracca may also suppress NF-κB signaling pathways, dampening cytokine release. Additionally, cyanogenic glycosides and lectins present in the plant may interact with glucose metabolism enzymes, potentially inhibiting alpha-glucosidase activity and contributing to observed antidiabetic effects at the genus level.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specific to Vicia cracca exist. Reviews of the Vicia genus suggest potential benefits, but these lack human trial data and PMIDs.

Clinical Summary

No published randomized controlled trials or formal human clinical studies specifically investigate Vicia cracca as a therapeutic intervention. Evidence is extrapolated from in vitro studies and animal models examining the broader Vicia genus, where ethanolic extracts have demonstrated dose-dependent reductions in oxidative stress markers such as malondialdehyde (MDA) and improvements in superoxide dismutase (SOD) activity. Rodent models using Vicia species extracts at doses of 200–400 mg/kg body weight have shown modest blood glucose-lowering effects, but these findings have not been replicated in humans. The overall evidence base is preliminary and insufficient to support clinical recommendations.

Nutritional Profile

Cow Vetch (Vicia cracca) seeds contain approximately 24–30% crude protein by dry weight, with a notable amino acid profile including lysine (~1.5–2.0 g/100g), arginine, and leucine, though methionine and cysteine are limiting amino acids common to legumes. Carbohydrate content is approximately 50–55% dry weight, with dietary fiber estimated at 8–12% including both soluble and insoluble fractions. Crude fat is low at approximately 1.5–3.0% dry weight, primarily composed of linoleic acid (omega-6) and small amounts of linolenic acid (omega-3). Starch content is significant at roughly 35–40% dry weight. Key minerals identified include calcium (~1.2–1.8 mg/g dry weight), phosphorus (~3.5–4.5 mg/g), iron (~0.08–0.12 mg/g), magnesium (~1.5–2.0 mg/g), and potassium (~8–12 mg/g). Vitamin content is typical of the Vicia genus, with B-vitamins including thiamine (B1) and riboflavin (B2) present in modest amounts (~0.3–0.5 mg/100g range), along with folate. Bioactive compounds include cyanogenic glycosides (vicine and convicine, ~0.5–2.0 mg/g in seeds), which reduce bioavailability and pose toxicity concerns without proper preparation; tannins (~2–5 g/100g in seed coats) that act as antinutritional factors reducing protein digestibility by 10–20%; flavonoids including kaempferol and quercetin glycosides identified in aerial parts at genus level; and lectins present in raw seeds that are denatured by cooking. Chlorogenic acids and other phenolic compounds have been detected in leaf and stem material. Bioavailability is significantly compromised by antinutritional factors; soaking and boiling are essential to reduce vicine, convicine, tannins, and lectins before any consumption. Leaves and young shoots used in traditional contexts contain lower concentrations of these antinutrients compared to mature seeds. Specific quantitative data for micronutrients in V. cracca leaves versus seeds remains limited in published literature.

Preparation & Dosage

There are no clinically studied dosage ranges due to the absence of human trials. Traditional uses involve unspecified amounts of cooked seeds or leaves. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Fenugreek, Milk Thistle, Red Clover, Alfalfa, Dandelion

Safety & Interactions

Cow vetch contains cyanogenic glycosides and lectins that may be toxic if consumed in large quantities, particularly from raw plant material, causing symptoms such as nausea, vomiting, or neurotoxicity. Individuals taking antidiabetic medications such as metformin or insulin should exercise caution due to potential additive hypoglycemic effects suggested by genus-level preclinical data. Vicia cracca is not recommended during pregnancy or breastfeeding due to the presence of potentially teratogenic alkaloids and the complete absence of human safety data. Individuals with legume allergies, particularly to vetch or bean-family plants, should avoid this herb due to cross-reactivity risk.